View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet

LNA Santé : RN FY 2023: les chiffres sont assez conformes – Focus sur ...

>ROC – RNpg : en ligne avec le consensus - Le CA 2023 ressort à 736,1 M€ (+1,1% vs. +5,8% pour le CA hors immobilier), l’EBITDA 2023 atteint 148,8 M€ (+4,2% - css : 142,7 M€), le ROC 65 M€ (+1%) et le RNpg 23,4 M€ (-9,3%). Le parc en activité (incluant les lits en restructuration) représente 9 390 lits à fin 2023 (vs 9 335 en 2022) sur 85 établissements dont 8 376 lits en « régime de croisière ».LNA Santé guide sur une croissance organique de 4,5% en 2024 (CA d’e...

Geoffroy Michalet
  • Geoffroy Michalet

Cegedim : 2023 guidance met… but negative one-offs… and sluggish cash ...

>In line with the guidance, admittedly… but otherwise not great - Cegedim’s 2023 results came out in line. For the record, it had already released its revenue figures back in January (+11%).The aim was merely to achieve growth in recurring operating income. This it achieved, with reported recurring operating income increasing by +23% to € 31.7m and bringing the margin to 5.1% (+50bp), even though we had expected more.However, there are other factors that und...

Damien Choplain ... (+2)
  • Damien Choplain
  • Martial Descoutures

OSE Immunotherapeutics : FY 2023 results contained no surprises - deci...

>Financial visibility out to 2026 - OSE reported its FY 2023 results yesterday after market close The operating loss will be € 23.0m, compared with € 18.4m in 2022, impacted in particular by a fall in sales to € 2.2m in 2023 from €1 8.3m in 2022. R&D costs are down to €17.2m (vs € 26.9m in 2022), followed by G&A at € 6.0m (vs € 6.7m in 2022). On the balance sheet, cash and cash equivalents at end-December 2023 were € 18.7m (vs € 25.6m in 2022). Including the $ 4...

Martial Descoutures ... (+2)
  • Martial Descoutures
  • Oussema Denguir

Moderna : An increasingly structured vaccine franchise

>Acceleration of all programmes against latent viruses - Moderna's Vaccines Day highlighted a coherent and ambitious mRNA portfolio against infectious diseases (28 vaccine candidates in development). In addition to its COVID-19 vaccine, we are particularly impressed by the progress of its vaccine against congenital CytoMegaloVirus (phase III, fully recruited; n=7300), the probability of success of which is improving over time (justifying extensions of indications to a...

 PRESS RELEASE

EQS-News: BayWa AG rechnet im Geschäftsjahr 2024 mit Ergebnisverbesser...

EQS-News: BayWa AG / Schlagwort(e): Jahresergebnis BayWa AG rechnet im Geschäftsjahr 2024 mit Ergebnisverbesserung (News mit Zusatzmaterial) 28.03.2024 / 10:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Nummer: 01224-PIU05 | Datum 28.03.2024 BayWa AG rechnet im Geschäftsjahr 2024 mit Ergebnisverbesserung Die BayWa AG schließt das Geschäftsjahr 2023 mit einem operativen Ergebnis von 304,0 Mio. Euro knapp unter der Jahresprognose ab. Der rasante Zinsanstieg belastet das Ergebnis über alle Geschäftsbereiche hinweg. Nach Zinsen un...

 PRESS RELEASE

EQS-News: BayWa AG expects earnings to improve in the financial year 2...

EQS-News: BayWa AG / Key word(s): Annual Results BayWa AG expects earnings to improve in the financial year 2024 (news with additional features) 28.03.2024 / 10:30 CET/CEST The issuer is solely responsible for the content of this announcement. Number: 01224-PIU05 | Date 28 March 2024 BayWa AG expects earnings to improve in the financial year 2024 BayWa AG closes the financial year 2023 with operating earnings of €304.0 million, just below the forecast for the year. The rapid rise in interest rates is having a negative effect on earnings across all business divisions. A...

 PRESS RELEASE

RM plc: Publication of 2023 Annual Report and Financial Statements

RM plc (RM.) RM plc: Publication of 2023 Annual Report and Financial Statements 28-March-2024 / 09:36 GMT/BST   28 March 2024     RM plc (“RM” or the “Company”)   Publication of 2023 Annual Report and Financial Statements   RM announces, in accordance with Listing Rules 9.6.1 and 9.6.3, that the Annual Report and Financial Statements for the year ended 30 November 2023 (the "Annual Report and Financial Statements 2023") have today been submitted to the Financial Conduct Authority via the National Storage Mechanism ("NSM"), where they will shortly be available for viewing at...

Jean-François Granjon
  • Jean-François Granjon

Quadient : Real growth drivers… for the next road map

>Targets broadly reached for the 2021-2023 road map - During the roadshow, the management (CEO, CFO, HIR) first of all gave a recap on the performances and the achievement of the targets in the 2021-2023 plan (phase II “Drive Sustainable Value”, which followed on from the “Transform” plan in 2019-2020) even though the mix is a little different from what was expected. We would point out the remarkable performances in the historical MRS business with a 2021-2023 CAGR of...

D''Amico International Shipping: 1 director

A director at D'Amico International Shipping sold 80,000 shares at 6.580EUR and the significance rating of the trade was 90/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...

Christophe Chaput
  • Christophe Chaput

Knaus Tabbert AG : 2023 results and 2024 targets broadly in line with ...

>2023 results in line with forecasts: EBITDA of € 123.8m vs € 123m estimated - For 2023, Knaus Tabbert has published results that were broadly in line with estimates. The publication was characterised by: 1/ sales growth of 37.3% to € 1,441m (already published), EBITDA of € 123.8m (vs our forecast of € 123m) i.e. an increase of 76.4%. The EBITDA margin was therefore 8.6%, which is in line with the group’s forecasts (EBITDA margin of 8.5% and 9%). Over and above volume...

Emmanuel Matot
  • Emmanuel Matot

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 28/03/2024

Hormis les Etats-Unis, les marchés de la construction devraient continuer à reculer en 2024 (-2% en Europe) avant de rebondir à la faveur d’une baisse des taux. Dans ce contexte, la différenciation entre les groupes se fera essentiellement sur leur capacité de résistance (mix géographique et prix/ coûts), l’allocation du capital (et situations spéciales) et leur valorisation. Face à cet environnement, nous relevons nos recommandations sur KONE (la modernisation comme relais de la Chin...

 PRESS RELEASE

EQS-News: Invitation to the 11th International Investment Forum (IIF) ...

EQS-News: GBC AG / Key word(s): Conference/Miscellaneous Invitation to the 11th International Investment Forum (IIF) - [ONLINE] on April 17, 2024 28.03.2024 / 10:30 CET/CEST The issuer is solely responsible for the content of this announcement. Dear Ladies and Gentlemen, we are pleased to invite you to participate online in the 11th International Investment Forum (IIF) on April 17, 2024 from 09:55 am (CET). The IIF is taking place for the eleventh time since its launch in 2021 and, as an online investor conference, offers the perfect platform for investors to get in tou...

 PRESS RELEASE

EQS-News: Einladung zum 11. International Investment Forum (IIF) - [ON...

EQS-News: GBC AG / Schlagwort(e): Konferenz/Sonstiges Einladung zum 11. International Investment Forum (IIF) - [ONLINE] am 17. April 2024 28.03.2024 / 10:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Sehr geehrte Damen und Herren, wir freuen uns, Sie herzlich zur Online-Teilnahme am 11. International Investment Forum (IIF) am 17. April 2024 ab 09:55 Uhr (MEZ) einzuladen. Das IIF findet bereits zum elften Mal seit seiner Gründung im Jahr 2021 statt und bietet als Online-Investorenkonferenz eine perfekte Plattform, auf der Invest...

Carole Braudeau
  • Carole Braudeau

Credit Morning 03/28/2024

Ardagh set to receive offers for Trivium Klockner Pentaplast: another very weak performance in Q4 Moody’s cuts Altice France’s corporate rating to Caa2/negative from B3/negative Casino: successful implementation of the financial restructuring>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 28/03/2024

Ardagh s’apprêterait à recevoir des offres pour Trivium Klockner Pentaplast : une performance à nouveau très faible au T4 Moody’s dégrade le rating d’Altice France de B3/négative à Caa2/négative Casino : réalisation effective de la restructuration financière>...

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet

LNA Santé : FY 2023 results: mostly in line – Focus on execution

>EBIT – Net profit: in line with the consensus - Sales totalled € 736.1m in 2023 (+1.1% vs +5.8% for sales ex-property), EBITDA € 148.8m (+4.2% - Css: € 142.7m), EBIT € 65m (+1%) and attributable net profit € 23.4m (-9.3%). The operating network (including beds undergoing restructuring) represented 9,390 beds at the end of 2023 (up from 9,335 in 2022) at 85 facilities, including 8,376 beds at “cruising speed”.LNA Santé guided for organic sales growth of +4.5% in ...

Syngene International Ltd: 1 director

A director at Syngene International Ltd sold 2,804 shares at 714.550INR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

 PRESS RELEASE

Veolia Environnement : Document d’enregistrement universel / Rapport f...

PARIS--(BUSINESS WIRE)-- Regulatory News: Veolia Environnement (Paris:VIE) annonce que la version anglaise de son document d’enregistrement universel 2023 est accessible sur le site internet de la société à l’adresse : Des exemplaires du document d’enregistrement universel sont également disponibles au siège administratif de la société, 30, rue Madeleine Vionnet à Aubervilliers (93300). Les documents suivants sont intégrés dans le document d’enregistrement universel : le rapport financier annuel 2023 ; les éléments du rapport sur le gouvernement d’entreprise (inclus dans le rapp...

Forza Lithium Corp: 1 director

A director at Forza Lithium Corp bought 1,400,000 shares at 0.000CAD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

Carsten Brzeski
  • Carsten Brzeski

German labour market remains resilient on the outside but shows weaken...

Unemployment this month dropped less than it generally has done in March since the financial crisis, suggesting that the very gradual cooling or turning of the labour market continues

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch